Genetics in Efavirenz Metabolism, the GEM study

Genetics in Efavirenz Metabolism, the GEM study - the GEM study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32907

Enrollment

120

Registered

2008-11-19

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DNA make-up Genetic marker

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients who are being treated with efavirenz and are monitord in the participating hospitals

Exclusion criteria

Exclusion criteria: HIV infected patients that do not use efavirenz

Design outcomes

Primary

Measure	Time frame
Difference in variation of genetic markers, for example CYP2B6 (subtype 6, 7 and *18), in the metabolism of efavirenz, between case and control population.	—

Secondary

Measure	Time frame
Demography of participants	—

Countries

Netherlands

Outcome results